Altamira Therapeutics Ltd (CYTO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,100 | -6,190 | -460 | -7,660 | -26,280 |
| Depreciation Amortization | 1,360 | 930 | 600 | 280 | 1,070 |
| Other Working Capital | 1,890 | 2,370 | 1,960 | 2,760 | -4,870 |
| Other Operating Activity | -11,000 | -11,520 | -12,100 | 460 | 620 |
| Operating Cash Flow | $-22,850 | $-14,410 | $-10,000 | $-4,160 | $-29,460 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -170 | -100 | -80 | -50 | -400 |
| Other Investing Activity | 6,280 | 11,120 | 11,120 | 0 | 22,720 |
| Investing Cash Flow | $6,110 | $11,020 | $11,040 | $-50 | $22,320 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 18,900 | 20 | 10 | -6 | 24,430 |
| Financing Cash Flow | $18,900 | $20 | $10 | $-6 | $24,430 |
| Beginning Cash Position | 30,330 | 30,330 | 30,330 | 30,330 | 13,040 |
| End Cash Position | 32,500 | 26,970 | 31,400 | 26,110 | 30,330 |
| Net Cash Flow | $2,170 | $-3,360 | $1,060 | $-4,220 | $17,290 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,850 | -14,410 | -10,000 | -4,160 | -29,460 |
| Free Cash Flow | -22,850 | -14,410 | -10,000 | -4,160 | -29,460 |